Skip to main content
. 2013 Apr 20;16(4):203–210. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2013.04.06

2.

66例患者皮疹与疗效的关系

The relationship between rash and effect of 66 patients

Outcome Gefitinib Erlotinib P
PR:partical response; SD:stable disease; PD:progressive disease;
DCR:disease control rate; RR:response rate.
PR 25 (51.0%) 7 (41.2%)
SD 20 (40.8%) 8 (47.1%)
PD 4 (8.2%) 2 (11.7%)
DCR (%) 91.1 86.7 0.643
RR (%) 51.0 41.2 0.578